Daptomycin
- Product NDC
- 69097-807
- 11-digit product format
- 690970807
- Labeler code
- 69097
- Product ID
- 69097-807_f23eb777-6de7-4b66-8fe9-1f0a70e7f225
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Daptomycin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Cipla USA Inc.
- Application
- ANDA212513
- Marketing category
- ANDA
- Marketing start
- 2019-09-23
- Marketing end
- 0000-00-00
- Substance
- DAPTOMYCIN
- Active strength
- 500 mg/10mL
- Pharmacologic classes
- Lipopeptide Antibacterial [EPC],Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-807 | DAPTOMYCIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CIPLA USA INC.] | 6 | Legacy NDC | 20210326_74c9700f-80b5-4665-88ca-1814c0150a29.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-807-37 | 69097080737 | 1 VIAL, SINGLE-DOSE in 1 CARTON (69097-807-37) > 10 mL in 1 VIAL, SINGLE-DOSE | 2019-09-23 | 0000-00-00 | No | No | Current |